Literature DB >> 22946656

Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.

Shao-Bin Cheng1, Li-Chen Wu, Yun-Chih Hsieh, Chi-Hao Wu, Yu-Ju Chan, Li-Hsun Chang, Chieh-Ming J Chang, Shih-Lan Hsu, Chieh-Lin Teng, Chun-Chi Wu.   

Abstract

The mechanisms underlying the antiproliferative and antitumor activities of aromatic turmerone (ar-turmerone), a volatile turmeric oil isolated from Curcuma longa Linn., have been largely unknown. In this study, 86% pure ar-turmerone was extracted by supercritical carbon dioxide and liquid-solid chromatography and its potential effects and molecular mechanisms on cell proliferation studied in human hepatocellular carcinoma cell lines. Ar-turmerone exhibited significant antiproliferative activity, with 50% inhibitory concentrations of 64.8 ± 7.1, 102.5 ± 11.5, and 122.2 ± 7.6 μg/mL against HepG2, Huh-7, and Hep3B cells, respectively. Ar-turmerone-induced apoptosis, confirmed by increased annexin V binding and DNA fragmentation, was accompanied by reactive oxygen species (ROS) production, mitochondrial membrane potential dissipation, increased Bax and p53 up-regulated modulator of apoptosis (PUMA) levels, Bax mitochondrial translocation, cytochrome c release, Fas and death receptor 4 (DR4) augmentation, and caspase-3, -8, and -9 activation. Exposure to caspase inhibitors, Fas-antagonistic antibody, DR4 antagonist, and furosemide (a blocker of Bax translocation) effectively abolished ar-turmerone-triggered apoptosis. Moreover, ar-turmerone stimulated c-Jun N-terminal kinase (JNK) and extracellular signal-related kinase (ERK) phosphorylation and activation; treatment with JNK and ERK inhibitors markedly reduced PUMA, Bax, Fas, and DR4 levels and reduced apoptosis but not ROS generation. Furthermore, antioxidants attenuated ar-turmerone-mediated ROS production; mitochondrial dysfunction; JNK and ERK activation; PUMA, Bax, Fas, and DR4 expression; and apoptosis. Taken together, these results suggest that ar-turmerone-induced apoptosis in HepG2 cells is through ROS-mediated activation of ERK and JNK kinases and triggers both intrinsic and extrinsic caspase activation, leading to apoptosis. On the basis of these observations, ar-turmerone deserves further investigation as a natural anticancer and cancer-preventive agent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22946656     DOI: 10.1021/jf301882b

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  12 in total

1.  Inhaled turmerones can be incorporated in the organs via pathways different from oral administration and can affect weight-gain of mice.

Authors:  Yuki Takemoto; Chihiro Kishi; Hinano Ehira; Nobutaka Matsui; Taichi Yamaguchi; Yuri Yoshioka; Shinichi Matsumura; Tatsuya Moriyama; Nobuhiro Zaima
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

2.  CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.

Authors:  Huimin Zhou; Yanping Li; Xiaobo Song; Yongfu Zhao; Lei Cheng; Lifen Zhao; Li Jia
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

3.  Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.

Authors:  Guo-Hua Qiu; Xiaojin Xie; Fang Xu; Xiaohao Shi; Yue Wang; Linhong Deng
Journal:  Cytotechnology       Date:  2014-07-08       Impact factor: 2.058

Review 4.  Nanotechnology-based approaches applied to nutraceuticals.

Authors:  Akanksha R Singh; Prasanna Kumar Desu; Ramya Krishna Nakkala; Vanitha Kondi; Sushma Devi; Mohammad Sarwar Alam; Hinna Hamid; Rajani B Athawale; Prashant Kesharwani
Journal:  Drug Deliv Transl Res       Date:  2021-03-18       Impact factor: 4.617

5.  The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.

Authors:  Chun-Chi Wu; Keh-Feng Huang; Tsung-Ying Yang; Ya-Ling Li; Chi-Luan Wen; Shih-Lan Hsu; Tzu-Hsiu Chen
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  Evaluation of phenolic profile, antioxidant and anticancer potential of two main representants of Zingiberaceae family against B164A5 murine melanoma cells.

Authors:  Corina Danciu; Lavinia Vlaia; Florinela Fetea; Monica Hancianu; Dorina E Coricovac; Sorina A Ciurlea; Codruţa M Şoica; Iosif Marincu; Vicentiu Vlaia; Cristina A Dehelean; Cristina Trandafirescu
Journal:  Biol Res       Date:  2015-01-12       Impact factor: 5.612

7.  Chemotaxonomic Characterization and in-Vitro Antimicrobial and Cytotoxic Activities of the Leaf Essential Oil of Curcuma longa Grown in Southern Nigeria.

Authors:  Emmanuel E Essien; Jennifer Schmidt Newby; Tameka M Walker; William N Setzer; Olusegun Ekundayo
Journal:  Medicines (Basel)       Date:  2015-12-21

8.  Essential oil content of the rhizome of Curcuma purpurascens Bl. (Temu Tis) and its antiproliferative effect on selected human carcinoma cell lines.

Authors:  Sok-Lai Hong; Guan-Serm Lee; Syarifah Nur Syed Abdul Rahman; Omer Abdalla Ahmed Hamdi; Khalijah Awang; Nurfina Aznam Nugroho; Sri Nurestri Abd Malek
Journal:  ScientificWorldJournal       Date:  2014-08-11

Review 9.  Dietary Natural Products for Prevention and Treatment of Liver Cancer.

Authors:  Yue Zhou; Ya Li; Tong Zhou; Jie Zheng; Sha Li; Hua-Bin Li
Journal:  Nutrients       Date:  2016-03-10       Impact factor: 5.717

Review 10.  Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations.

Authors:  Akhila Nair; Augustine Amalraj; Joby Jacob; Ajaikumar B Kunnumakkara; Sreeraj Gopi
Journal:  Biomolecules       Date:  2019-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.